Pheo Para Alliance Recognizes UCLA as Center of Excellence for Rare Endocrine Illness.
Pheo Para Alliance, a patient advocacy organization dedicated to supporting those with pheochromocytoma (pheo) and paraganglioma (para), a rare neuroendocrine tumor, has designated the UCLA Endocrine Center as a Center of Excellence, the first designation made on the west coast. The Center of Excellence Program recognizes institutions worldwide for providing cutting-edge, quality, multi-disciplinary care and participating in pheo and para and related research. UCLA’s announcement brings the total list of Clinical Centers and Centers of Excellence to seven, with more announcements slated throughout 2021. Full press release >
The maintenance of steady and predictable thyroid hormone levels in the blood is essential to health. What is the best way to take thyroid hormone? >
Appointment Reminders by Text - Skip the phone calls and receive your appointment reminders by text >
A new technique called Transoral Endoscopic Thyroidectomy Vestibular Approach (TOETVA) has been developed. With this surgery, the thyroid gland is removed without leaving any visible scars in the neck. Scarless Thyroid and Parathyroid Surgery >
The UCLA Endocrine Center has once again earned a coveted spot in the annual U.S. News & World Report survey. UCLA Endocrine Center is consistently ranked as one of the top endocrinology programs in the nation, and that is the result of our commitment to providing outstanding and personalized patient care. We are proud to be part of UCLA Health with our hospitals ranked as No. 1 in both Los Angeles and California and No. 3 nationally. U.S. News & World Report > | UCLA Health Newsroom >